| Product Code: ETC7622539 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Acute Myeloid Leukemia Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Acute Myeloid Leukemia Market - Industry Life Cycle |
3.4 Ireland Acute Myeloid Leukemia Market - Porter's Five Forces |
3.5 Ireland Acute Myeloid Leukemia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Ireland Acute Myeloid Leukemia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ireland Acute Myeloid Leukemia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Acute Myeloid Leukemia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Ireland Acute Myeloid Leukemia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Acute Myeloid Leukemia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of acute myeloid leukemia in Ireland |
4.2.2 Advancements in treatment options and therapies for acute myeloid leukemia |
4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care |
4.3 Market Restraints |
4.3.1 High cost of AML treatments and therapies |
4.3.2 Limited access to specialized healthcare services in certain regions of Ireland |
4.3.3 Stringent regulatory requirements for approval of new AML treatments |
5 Ireland Acute Myeloid Leukemia Market Trends |
6 Ireland Acute Myeloid Leukemia Market, By Types |
6.1 Ireland Acute Myeloid Leukemia Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Myeloblastic, 2021- 2031F |
6.1.4 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Promyelocytic, 2021- 2031F |
6.1.5 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Myelomonocytic, 2021- 2031F |
6.2 Ireland Acute Myeloid Leukemia Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.2.6 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Acute Myeloid Leukemia Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Acute Myeloid Leukemia Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Acute Myeloid Leukemia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Acute Myeloid Leukemia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Acute Myeloid Leukemia Market Import-Export Trade Statistics |
7.1 Ireland Acute Myeloid Leukemia Market Export to Major Countries |
7.2 Ireland Acute Myeloid Leukemia Market Imports from Major Countries |
8 Ireland Acute Myeloid Leukemia Market Key Performance Indicators |
8.1 Patient survival rates and remission rates |
8.2 Adoption rate of novel therapies and treatment modalities |
8.3 Number of clinical trials and research studies conducted in the field of AML in Ireland |
9 Ireland Acute Myeloid Leukemia Market - Opportunity Assessment |
9.1 Ireland Acute Myeloid Leukemia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Ireland Acute Myeloid Leukemia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ireland Acute Myeloid Leukemia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Acute Myeloid Leukemia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Ireland Acute Myeloid Leukemia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Acute Myeloid Leukemia Market - Competitive Landscape |
10.1 Ireland Acute Myeloid Leukemia Market Revenue Share, By Companies, 2024 |
10.2 Ireland Acute Myeloid Leukemia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here